-+ 0.00%
-+ 0.00%
-+ 0.00%

ABVC Biopharma Inc. Reports 103% Asset Growth and $350K Licensing Revenue Boost; EPS Loss Narrows in Q2 2025

Reuters·08/14/2025 11:04:33

Please log in to view news